About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

First Biosimilar Launched by Cipla for Rheumatic Disorders

by Kathy Jones on April 18, 2013 at 11:01 PM
Font : A-A+

 First Biosimilar Launched by Cipla for Rheumatic Disorders

Mumbai-based pharmaceutical company Cipla revealed that it has launched etanercept biosimilar drug in India to treat rheumatic disorders.

Cipla revealed that the drug will be sold under the brand name Etacept and will be manufactured by China-based Shanghai CP Guojian Pharmaceutical. Etacept will be the first drug marketed by Cipla biologics segment and will offer a treatment alternative to patients suffering from rheumatic disorders at a lower cost.

Advertisement

Cipla added that Etacept will be available in the form of a powder to be given by subcutaneous injection and will be priced at Rs 6,150.

"The higher cost of biologics has been a major hindrance, limiting its affordability and accessibility to millions of patients. We believe that introducing Etacept at a lower cost (30 per cent lesser compared to the innovator) will enable access of this drug to a greater number of patients in India. This can be enhanced further if we consider the results of a recent study that showed in patients, who were successfully treated with Etanercept for six months, a 50 per cent reduced dose worked just as well as continuing the current dose", Cipla's Medical Director Dr Jaideep Gogtay said.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Breast Cancer Awareness Month 2021 - It's time to RISE
First-Ever Successful Pig-To-Human Kidney Transplantation
World Osteoporosis Day 2021 -
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Rheumatoid Arthritis
Rheumatoid arthritis is a chronic inflammatory disease that causes pain, swelling, stiffness and ......
Diet, Nutrition and Supplements for Osteo-Arthritis and Rheumatoid Arthritis
Rheumatoid arthritis patients should consume a diet rich in natural antioxidant and ......
Oligoarthritis
Most parents when told that their child has arthritis find it hard to believe it, as arthritis is .....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use